Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/37197
Title: Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus.
Authors: 
Keywords: 
Mesh: 
Issue Date: 2018
Citation: Gut.2018 11;(67)11:2017-2024
Abstract: Recently approved direct acting antivirals provide transformative therapies for chronic hepatitis C virus (HCV) infection. The major clinical challenge remains to identify the undiagnosed patients worldwide, many of whom live in low-income and middle-income countries, where access to nucleic acid testing remains limited. The aim of this study was to develop and validate a point-of-care (PoC) assay for the qualitative detection of HCV RNA.
PMID: 29615488
URI: https://hdl.handle.net/20.500.12530/37197
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos
Hospitales > H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC6176522.pdf600.69 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.